FSD Pharma Inc Empfehlungs-Mittelwert
Was ist das Empfehlungs-Mittelwert von FSD Pharma Inc?
Empfehlungs-Mittelwert von FSD Pharma Inc ist 1.00
Was ist die Definition von Empfehlungs-Mittelwert?
Der empfohlene Mittelwert ist der Durchschnitt der Analystenbewertungen der Aktie von 1,0 (starker Kauf) bis 5,0 (starker Verkauf).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Empfehlungs-Mittelwert von Unternehmen in Technology Sektor auf NASDAQ im Vergleich zu FSD Pharma Inc
Was macht FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Unternehmen mit empfehlungs-mittelwert ähnlich FSD Pharma Inc
- FSD Pharma Inc hat Empfehlungs-Mittelwert von 1.00
- JOYY Inc hat Empfehlungs-Mittelwert von 1.05
- Honda Motor hat Empfehlungs-Mittelwert von 1.06
- Ares Capital Corp hat Empfehlungs-Mittelwert von 1.07
- Petroleo Brasileiro S.A. Petrobras hat Empfehlungs-Mittelwert von 1.08
- VNET Inc hat Empfehlungs-Mittelwert von 1.08
- Rocket Pharmaceuticals Inc hat Empfehlungs-Mittelwert von 1.08